12:00 AM
Jun 30, 2014
 |  BC Week In Review  |  Financial News  |  Proposed Offerings

Ultragenyx proposes follow-on

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Novato, Calif.
Business: Musculoskeletal, Endocrine/Metabolic
Date announced:2014-06-25
Type: Follow-on

Read the full 49 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >